×

CNS Response to be Featured on "The Doctors"

ALISO VIEJO, Calif., Jan. 27, 2015 (GLOBE NEWSWIRE) -- CNS Response, Inc. (OTCQB:CNSO)

CNS Response has been notified we will be featured on the Friday, January 30 episode of "The Doctors." The segment focuses on a patient, Ashley, who spent years searching for the right treatment for her anxiety. Ashley was a high achieving extroverted school leader who graduated magna cum laude from college. She didn't feel like herself and spent the next five years trying to figure out what was wrong and how to get her life back. Ashley and her mom, Kim, touchingly describe their struggle and how her doctor's use of the PEER Report has brought joy and success back to this smart articulate young woman.

Sharing information about the PEER Report has become a calling for Ashley: "I don't want other people to waste time trying things that don't work. My Mom was nervous about going on TV. I reminded her of all the other people searching for answers by themselves. Not everyone has a super supporter like my Mom."

Dr. Mark Schiller M.D., interviewed on the segment and a PEER Medical Director, said: "In the absence of an objective tool like PEER, Psychiatrists rely on trial and error. Ashley's case shows the human cost of her lengthy search for an effective treatment."

The CNS Response team would like to thank Ashley, Kim, Drs. Schiller, Travis and Ross for sharing this story.

"The Doctors," a popular daytime television program airs nationally at 9:00 a.m., please check your local listings for the channel in your area.

About CNS Response Inc.

CNS Response (www.cnsresponse.com) provides a unique set of reference data and analytic tools for clinicians and researchers in psychiatry. While treatment for mental disorders has doubled in the last 20 years, it is estimated that 17 million Americans have failed two or more medication therapies for their mental disorders. The Company's Psychiatric EEG Evaluation Registry, or PEER Online, is a new registry and reporting platform that allows medical professionals to exchange treatment outcome data for patients referenced to objective neurophysiology data obtained through a standard electroencephalogram (EEG). Based on the company's original physician-developed database, there are now more than 37,350 outcomes for over 9,900 unique patients in the PEER registry. The objective of PEER Online is to avoid trial and error pharmacotherapy, which is the dominant approach for treatment resistant patients.

To read more about the benefits of this patented technology for patients, physicians and payers, please visit www.cnsresponse.com. Medical professionals interested in learning more can contact CNS Response representatives at PEERinfo@cnsresponse.com.

Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995

Except for the historical information contained herein, the matters discussed are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. These forward-looking statements involve risks and uncertainties as set forth in the Company's filings with the Securities and Exchange Commission. These risks and uncertainties could cause actual results to differ materially from any forward-looking statements made herein.

CONTACT: Media Relations: Lauren Jenkins Scoutcomms 1-877-565-3323 ljenkins@scoutcommsusa.com Investor Relations: Dave Gentry RedChip Companies 1-800-733-2447, ext. 104 dave@redchip.com

Source:CNS Response